Ionis Pharmaceuticals (IONS) Minority Interest (2009 - 2020)

Ionis Pharmaceuticals' Minority Interest history runs 5 years deep, the most recent figure standing at $223.2 million for Q3 2020.

• In Q3 2020, Minority Interest rose 38.08% year-over-year to $223.2 million; the TTM figure through Sep 2020 stood at $223.2 million (up 38.08% YoY), while the FY2019 annual figure was $213.5 million, up 53.47% from the prior year.
• Minority Interest was $223.2 million for Q3 2020 at Ionis Pharmaceuticals, up from $217.6 million in the prior quarter.
• In the past five years, Minority Interest ranged from a high of $223.2 million in Q3 2020 to a low of $84.3 million in Q4 2017.
• Historically, Minority Interest has averaged $157.2 million across 4 years, with a median of $161.7 million in 2019.
• The sharpest annual moves came in 2019 and 2020: Minority Interest jumped 109.74% in 2019, then advanced 15.87% in 2020.
• A 4-year view of Minority Interest shows it stood at $84.3 million in 2017, then soared by 65.05% to $139.1 million in 2018, then surged by 53.47% to $213.5 million in 2019, then increased by 4.58% to $223.2 million in 2020.
• The last three Minority Interest figures came in at $223.2 million (Q3 2020), $217.6 million (Q2 2020), and $210.2 million (Q1 2020), per Business Quant data.